title: Resveratrol, a sirtuin 1 activator, increases IL-6 production by peripheral blood mononuclear cells of patients with knee osteoarthritis.
abstract: BACKGROUND
  Sirtuin 1 (Sirt1) is a nuclear enzyme from the class III histone deacetylases that modulates gene expression and is involved in bone and cartilage remodeling. The goal of our study was to evaluate Sirt1 activity in peripheral blood mononuclear cells in patients with osteoarthritis in comparison with control patients, and to determine the relationship between Sirt1 activity and production of TNFα, IL-6 and IL-8 by peripheral blood mononuclear cells after ex vivo treatment with resveratrol, a Sirt1 activator.
  
  
  RESULTS
  A prospective study was performed to compare the activity of Sirt1 in patients with primary osteoarthritis of the knee (American College of Rheumatology criteria) with its activity in controls. Peripheral blood mononuclear cells were isolated from peripheral blood, and Sirt1 activity evaluated from cytoplasmic and nuclear compartments using a fluorometric assay. Culture supernatant levels of TNFα, IL-6, and IL-8 were quantified before and after resveratrol ex vivo treatment. Nineteen patients with symptomatic knee osteoarthritis (age 64 ±9 years) and 18 controls (age 54 ±13 years) were included. No differences were found in cytoplasmic or nuclear Sirt1 activity between patients and controls. After resveratrol treatment, no changes in TNFα or IL-8 levels were found, but a significant dose-dependent increase in IL-6 levels was demonstrated in patients with osteoarthritis, but not controls. Sirt1 activity did not correlate with clinical activity (Lequesne's index) or inflammation (erythrocyte sedimentation rate, C-reactive protein).
  
  
  CONCLUSIONS
  Sirt1 activity (cytoplasmic and nuclear) from peripheral blood mononuclear cells did not differ between patients with osteoarthritis and controls. Ex vivo treatment of peripheral blood mononuclear cells with resveratrol was associated with a dose-dependent increase in IL-6 levels only in patients with osteoarthritis.
authors.affiliation: Department of Rheumatology, CHRU de Besançon, Boulevard Fleming, F-25030 Besançon, France. dwendling@chu-besancon.fr.
authors.forename: Daniel
authors.initials: D
authors.lastname: Wendling
authors.forename: Wasim
authors.initials: W
authors.lastname: Abbas
authors.forename: Marie
authors.initials: M
authors.lastname: Godfrin-Valnet
authors.forename: Xavier
authors.initials: X
authors.lastname: Guillot
authors.forename: Kashif Aziz
authors.initials: KA
authors.lastname: Khan
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Cedoz
authors.forename: Lucile
authors.initials: L
authors.lastname: Baud
authors.forename: Clément
authors.initials: C
authors.lastname: Prati
authors.forename: Georges
authors.initials: G
authors.lastname: Herbein